Sponsor Dossier
Astellas Pharma
Sponsor Dossier for Astellas Pharma. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ADVAGRAF XL
- Brand: BETMIGA
- Brand: FLOMAXTRA
- Brand: IZERVAY
- Brand: PADCEV
- Brand: PROGRAF
- Brand: PROGRAF-XL
- Brand: VEOZA
- Device (sponsor): Surgical procedure kit, ophthalmic, medicated, single-use
About
Astellas Pharma is an Australian Private Company with ABN 81147915482, registered in New South Wales. The entity is currently Active.
Portfolio
Astellas Pharma has 12 brands on the ARTG, of which 12 are indexable and 11 carry a Product Information document. 7 brands are PBS-listed, 9 have a PBAC outcome on record, and 6 have an AusPAR on record. Notable brands include ADVAGRAF XL, BETMIGA, FLOMAXTRA, IZERVAY, PADCEV, PROGRAF, PROGRAF-XL, VEOZA, VESICARE, VYLOY, XOSPATA, XTANDI.
Therapeutic focus
— Immunology: 3 brands — Oncology: 3 brands — Reproductive Health: 2 brands — Ophthalmology: 1 brand — Other: 1 brand — Renal: 1 brand — Haematology: 1 brand
PBS footprint
7 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2026-03-01, across 9 brands with a PBAC outcome on record. The latest AusPAR is 2025-09-30, across 6 brands with an AusPAR on record.